juglone has been researched along with Thyroid Cancer, Anaplastic in 1 studies
juglone: structure
juglone : A hydroxy-1,4-naphthoquinone that is 1,4-naphthoquinone in which the hydrogen at position 5 has been replaced by a hydroxy group. A plant-derived 1,4-naphthoquinone with confirmed antibacterial and antitumor activities.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaikwad, S | 1 |
| Chakraborty, A | 1 |
| Salwe, S | 1 |
| Patel, V | 1 |
| Kulkarni, S | 1 |
| Banerjee, S | 1 |
1 other study available for juglone and Thyroid Cancer, Anaplastic
| Article | Year |
|---|---|
Juglone-ascorbic acid synergy inhibits metastasis and induces apoptotic cell death in poorly differentiated thyroid carcinoma by perturbing SOD and catalase activities.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Ascorbic Acid; Cel | 2018 |